WHO ICTRP trial
Effects of Remimazolam vs. Propofol on Early Postoperative Cognitive Recovery in…
ChiCTR2500109239 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500109239 |
|---|---|
| Public title | Effects of Remimazolam vs. Propofol on Early Postoperative Cognitive Recovery in Day-Case Endoscopic Ear Surgery: A Randomized Controlled Trial |
| Scientific title | Effects of Remimazolam vs. Propofol on Early Postoperative Cognitive Recovery in Day-Case Endoscopic Ear Surgery: A Randomized Controlled Trial |
| Primary sponsor | Shanghai Eye & ENT hosoital , Fudan university |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Early Postoperative Cognitive Recovery |
| Interventions | propofol:propofol +remifentanil ;remimazolam:remimazolam++remifentanil |
| Registration date | Sep 16, 2025 |
| Target size | propofol:45;remimazolam:45 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: